Key Takeaways

• The WALK device, developed by Lifespark Technologies, aims to reduce freezing of gait in Parkinson’s disease patients using a wearable, app, and cloud monitoring system.
• Clinical trials show a nearly 50% reduction in freezing episodes, enhancing mobility and quality of life for users.
• WALK exemplifies innovative approaches in India’s healthcare, addressing the increasing need for effective chronic disease management as the population ages.

Innovative Solution for Parkinson’s Patients

WALK is a wearable medical device designed to alleviate freezing of gait (FOG) in individuals with Parkinson’s disease. Created by Lifespark Technologies, a Mumbai-based startup, it integrates a lower-limb wearable, a mobile app, and a cloud monitoring system. Co-founded by Amey Desai and Dr. Devendra Desai, WALK arose from the urgent need to support approximately 7 million people in India affected by Parkinson’s disease, many of whom face significant mobility challenges.

The inspiration for WALK is both personal and scientific. Amey Desai’s exposure to Parkinson’s through his grandfather, combined with his academic background in neural motor control, informed the design of the device. Research indicates that walking involves not just conscious brain control but also spinal circuits and sensory feedback. When these cues fail in Parkinson’s, external rhythmic cues can help restore movement.

WALK acts as a non-invasive wearable that provides external sensory cues to help users overcome freezing episodes. Equipped with accelerometers, gyroscopes, and inertial measurement units, the device analyzes walking patterns continuously. Upon detecting irregularities like hesitation, it delivers gentle vibrations and mild electrical stimulation to the legs, facilitating coordinated movement.

Supporting this device is a smartphone application that allows users to customize settings, monitor walking performance, and access tailored physiotherapy exercises. The Pathfinder cloud platform securely stores gait data, enabling clinicians to remotely oversee patient progress and adjust treatment protocols. This integrated approach ensures continuous, personalized care locations beyond clinical environments.

The development of WALK follows a rigorous medical device lifecycle, starting in 2018 with prototype completion in 2021. The device achieved ISO 13485 certification and received a test license from India’s Central Drugs Standard Control Organisation, facilitating extensive safety and efficacy testing. Clinical trials at NIMHANS, Bengaluru, demonstrated a nearly 50% reduction in freezing episodes among 20 participants, validating the device’s complementary role alongside traditional therapies.

To date, almost 300 families in India have leveraged WALK, reporting increased walking confidence, reduced fear of falls, and improved independence in daily activities. Clinicians have noted enhancements in balance, mobility, and patient engagement with therapies, while remote monitoring has decreased the need for frequent hospital visits.

Priced around Rs 50,000, Lifespark is working to make WALK more accessible. The project underscores the potential of wearable, sensor-driven technologies in chronic disease management, particularly as the prevalence of Parkinson’s rises with an ageing population. WALK represents a convergence of engineering, clinical science, and digital health, offering a pathway to enhance India’s healthcare system through effective home-based rehabilitation and continuous monitoring solutions.

The content above is a summary. For more details, see the source article.